# ENCOrafenib With Binimetinib in bRAF NSCLC

> clinical trial · VERIFIED · 2026-08-11

Status: ACTIVE_NOT_RECRUITING · Sponsor: Intergroupe Francophone de Cancerologie Thoracique · Condition: Non Small Cell Lung Cancer

- Company: Intergroupe Francophone de Cancerologie Thoracique
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04526782

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.